State Street Corp Cytek Biosciences, Inc. Transaction History
State Street Corp
- $2.8 Trillion
- Q3 2025
A detailed history of State Street Corp transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, State Street Corp holds 4,084,368 shares of CTKB stock, worth $22.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,084,368
Previous 4,173,763
2.14%
Holding current value
$22.5 Million
Previous $14.2 Million
0.13%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CTKB
# of Institutions
152Shares Held
73MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY17.1MShares$93.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.93MShares$38.1 Million0.0% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$36.6 Million0.69% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.96MShares$27.3 Million0.74% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.42MShares$18.8 Million0.01% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $740M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...